Travel-Related Tick-Borne Encephalitis, Israel, 2006-2014

Insights

Four tick-borne encephalitis (TBE) cases were reported in Israeli travelers between 2006-2014. Incidence rates suggest TBE vaccination may be warranted for travelers to Sweden, Switzerland, Austria, and Germany.

Area of Science:

  • Epidemiology
  • Infectious Diseases
  • Travel Medicine

Background:

  • Tick-borne encephalitis (TBE) is a significant viral infection transmitted by ticks.
  • Understanding TBE risk for international travelers is crucial for public health.
  • Previous data on TBE incidence among Israeli travelers to endemic European regions is limited.

Purpose of the Study:

  • To determine the incidence of TBE among Israeli travelers visiting specific European countries.
  • To assess the risk of TBE infection in relation to travel destinations.
  • To inform vaccination recommendations for travelers based on calculated incidence rates.

Main Methods:

  • Retrospective analysis of TBE cases among Israeli travelers from 2006 to 2014.
  • Calculation of TBE incidence rates per 100,000 travelers per year for Sweden, Switzerland, Austria, and Germany.
  • Comparison of incidence rates across different destinations.

Main Results:

  • Four TBE cases were identified among Israeli travelers during the study period.
  • Calculated TBE incidence rates were highest in Sweden (321.0/100,000 traveler-years), followed by Switzerland (45.0), Austria (13.2), and Germany (7.5).
  • Significant variation in TBE incidence was observed across the studied European countries.

Conclusions:

  • The calculated TBE incidence rates in travelers to Sweden, Switzerland, Austria, and Germany are notable.
  • These findings support the consideration of TBE vaccination for Israeli travelers visiting these regions.
  • The results align with World Health Organization recommendations for TBE prevention in endemic areas.